Here are seven articles published by Becker's Hospital Review this week, detailing two different drug recalls, the top health products recommended by pharmacists in 2017 and more.
1. Medical Design Excellence Awards names top medical devices of 2017
The Medical Device and Diagnostic Industry on June 13 announced the 2017 winners of the Medical Design Excellence Awards.
2. More than 48k bottles of Bristol-Myers' blood thinner recalled over dosing error
Bristol-Myers Squibb on June 10 recalled more than 48,000 bottles of its blood thinner Eliquis due to dosage issues.
3. 3 things to know about the Senate Health Committee's drug price hearing
The Senate Health, Education, Labor and Pensions Committee on Tuesday held the first of three hearings dedicated to the issue of high drug costs.
4. Top pharmacist-recommended health products for 2017
U.S. News & World Report — in collaboration with Pharmacy Times — on Tuesday released its 2017 list of the top health products recommended by pharmacists.
5. EpiPen scandal grounds for removal of Mylan board members, says advisory firm
Institutional Shareholder Services, a major shareholder advisory firm, is urging Mylan stockholders to vote for the removal of 10 board members, including board Chairman Robert Coury and CEO Heather Bresch.
6. SCOTUS ruling brings biosimilars to market faster: 4 things to know
The U.S. Supreme Court on Monday ruled drugmakers will no longer have to wait six months after regulatory approval to launch new biosimilar drugs.
7. Cancer drugs may be just as effective — and cheaper — at lower doses, oncologists say
Lower doses and shorter treatment periods may not reduce the efficacy of many cancer drugs, says a group of oncologists researching ways to lower cancer treatment costs.
More articles on supply chain:
Medical Design Excellence Awards names top medical devices of 2017
More than 48k bottles of Bristol-Myers' blood thinner recalled over dosing error
Takeda Pharma taps AI platform for drug development